- Home
- GDTC vs BRLT Comparison
GDTC vs BRLT Comparison
Compare GDTC & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- BRLT
- Stock Information
- Founded
- GDTC 2018
- BRLT 2005
- Country
- GDTC Singapore
- BRLT United States
- Employees
- GDTC N/A
- BRLT N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- BRLT Consumer Specialties
- Sector
- GDTC Health Care
- BRLT Consumer Discretionary
- Exchange
- GDTC Nasdaq
- BRLT Nasdaq
- Market Cap
- GDTC 23.7M
- BRLT 25.5M
- IPO Year
- GDTC 2023
- BRLT 2021
- Fundamental
- Price
- GDTC $2.13
- BRLT $1.79
- Analyst Decision
- GDTC Buy
- BRLT Buy
- Analyst Count
- GDTC 1
- BRLT 4
- Target Price
- GDTC $5.00
- BRLT $3.00
- AVG Volume (30 Days)
- GDTC 12.4K
- BRLT 59.2K
- Earning Date
- GDTC 01-01-0001
- BRLT 11-07-2024
- Dividend Yield
- GDTC N/A
- BRLT N/A
- EPS Growth
- GDTC N/A
- BRLT N/A
- EPS
- GDTC N/A
- BRLT 0.05
- Revenue
- GDTC $330,254.00
- BRLT $441,263,000.00
- Revenue This Year
- GDTC $4.46
- BRLT N/A
- Revenue Next Year
- GDTC N/A
- BRLT $3.38
- P/E Ratio
- GDTC N/A
- BRLT $35.39
- Revenue Growth
- GDTC N/A
- BRLT 0.53
- 52 Week Low
- GDTC $1.20
- BRLT $1.66
- 52 Week High
- GDTC $5.50
- BRLT $3.81
- Technical
- Relative Strength Index (RSI)
- GDTC 69.51
- BRLT 38.80
- Support Level
- GDTC $1.96
- BRLT $1.75
- Resistance Level
- GDTC $2.16
- BRLT $1.89
- Average True Range (ATR)
- GDTC 0.15
- BRLT 0.10
- MACD
- GDTC 0.03
- BRLT -0.02
- Stochastic Oscillator
- GDTC 84.07
- BRLT 18.10
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.